nodes	percent_of_prediction	percent_of_DWPC	metapath
Nadolol—Adams-Stokes syndrome—Rivastigmine—Alzheimer's disease	0.111	0.135	CcSEcCtD
Nadolol—Feeling cold—Donepezil—Alzheimer's disease	0.021	0.0255	CcSEcCtD
Nadolol—Intermittent claudication—Memantine—Alzheimer's disease	0.019	0.0232	CcSEcCtD
Nadolol—Cardiomegaly—Donepezil—Alzheimer's disease	0.0164	0.02	CcSEcCtD
Nadolol—Cardiomegaly—Memantine—Alzheimer's disease	0.0149	0.0182	CcSEcCtD
Nadolol—Abdominal bloating—Donepezil—Alzheimer's disease	0.0126	0.0153	CcSEcCtD
Nadolol—Pancreatitis acute—Memantine—Alzheimer's disease	0.0118	0.0143	CcSEcCtD
Nadolol—Throat sore—Donepezil—Alzheimer's disease	0.00832	0.0101	CcSEcCtD
Nadolol—Oropharyngeal discomfort—Donepezil—Alzheimer's disease	0.00824	0.01	CcSEcCtD
Nadolol—Hepatic enzyme increased—Galantamine—Alzheimer's disease	0.00818	0.00995	CcSEcCtD
Nadolol—Atrioventricular block—Galantamine—Alzheimer's disease	0.00797	0.0097	CcSEcCtD
Nadolol—Ventricular extrasystoles—Donepezil—Alzheimer's disease	0.00664	0.00808	CcSEcCtD
Nadolol—Oropharyngeal pain—Donepezil—Alzheimer's disease	0.00659	0.00802	CcSEcCtD
Nadolol—Extrasystoles—Memantine—Alzheimer's disease	0.00647	0.00787	CcSEcCtD
Nadolol—Dysarthria—Donepezil—Alzheimer's disease	0.00634	0.00771	CcSEcCtD
Nadolol—Extrasystoles—Rivastigmine—Alzheimer's disease	0.00633	0.0077	CcSEcCtD
Nadolol—Atrioventricular block—Donepezil—Alzheimer's disease	0.00618	0.00752	CcSEcCtD
Nadolol—Hepatic enzyme increased—Memantine—Alzheimer's disease	0.00575	0.007	CcSEcCtD
Nadolol—Cardiac failure—Galantamine—Alzheimer's disease	0.00575	0.007	CcSEcCtD
Nadolol—Lethargy—Galantamine—Alzheimer's disease	0.00573	0.00697	CcSEcCtD
Nadolol—Dysarthria—Rivastigmine—Alzheimer's disease	0.00563	0.00685	CcSEcCtD
Nadolol—Atrioventricular block—Memantine—Alzheimer's disease	0.00561	0.00683	CcSEcCtD
Nadolol—Disturbance in sexual arousal—Galantamine—Alzheimer's disease	0.00557	0.00678	CcSEcCtD
Nadolol—Dry eye—Donepezil—Alzheimer's disease	0.00554	0.00674	CcSEcCtD
Nadolol—Atrioventricular block—Rivastigmine—Alzheimer's disease	0.00549	0.00668	CcSEcCtD
Nadolol—Fluid retention—Rivastigmine—Alzheimer's disease	0.00505	0.00615	CcSEcCtD
Nadolol—Gastritis—Galantamine—Alzheimer's disease	0.00497	0.00605	CcSEcCtD
Nadolol—Pulmonary oedema—Memantine—Alzheimer's disease	0.00484	0.0059	CcSEcCtD
Nadolol—Cardiac failure congestive—Donepezil—Alzheimer's disease	0.0048	0.00584	CcSEcCtD
Nadolol—Pulmonary oedema—Rivastigmine—Alzheimer's disease	0.00474	0.00577	CcSEcCtD
Nadolol—Libido decreased—Donepezil—Alzheimer's disease	0.00469	0.00571	CcSEcCtD
Nadolol—Abdominal discomfort—Galantamine—Alzheimer's disease	0.00465	0.00566	CcSEcCtD
Nadolol—Sleep disorder—Memantine—Alzheimer's disease	0.00456	0.00555	CcSEcCtD
Nadolol—Sleep disorder—Rivastigmine—Alzheimer's disease	0.00446	0.00543	CcSEcCtD
Nadolol—Cardiac failure—Donepezil—Alzheimer's disease	0.00446	0.00543	CcSEcCtD
Nadolol—Disorientation—Memantine—Alzheimer's disease	0.00442	0.00537	CcSEcCtD
Nadolol—Cardiac failure congestive—Memantine—Alzheimer's disease	0.00436	0.0053	CcSEcCtD
Nadolol—Disturbance in sexual arousal—Donepezil—Alzheimer's disease	0.00432	0.00525	CcSEcCtD
Nadolol—Depression—Galantamine—Alzheimer's disease	0.00431	0.00525	CcSEcCtD
Nadolol—Affect lability—Donepezil—Alzheimer's disease	0.00428	0.00521	CcSEcCtD
Nadolol—Libido decreased—Memantine—Alzheimer's disease	0.00426	0.00518	CcSEcCtD
Nadolol—Amnesia—Memantine—Alzheimer's disease	0.00421	0.00512	CcSEcCtD
Nadolol—Libido decreased—Rivastigmine—Alzheimer's disease	0.00417	0.00507	CcSEcCtD
Nadolol—Irritability—Donepezil—Alzheimer's disease	0.00415	0.00505	CcSEcCtD
Nadolol—Mood swings—Donepezil—Alzheimer's disease	0.00412	0.00502	CcSEcCtD
Nadolol—Amnesia—Rivastigmine—Alzheimer's disease	0.00411	0.00501	CcSEcCtD
Nadolol—Cardiac failure—Memantine—Alzheimer's disease	0.00405	0.00493	CcSEcCtD
Nadolol—Lethargy—Memantine—Alzheimer's disease	0.00403	0.00491	CcSEcCtD
Nadolol—Dry skin—Donepezil—Alzheimer's disease	0.00399	0.00485	CcSEcCtD
Nadolol—Cardiac failure—Rivastigmine—Alzheimer's disease	0.00396	0.00482	CcSEcCtD
Nadolol—Bradycardia—Galantamine—Alzheimer's disease	0.00395	0.00481	CcSEcCtD
Nadolol—Diplopia—Memantine—Alzheimer's disease	0.00395	0.00481	CcSEcCtD
Nadolol—Disturbance in sexual arousal—Memantine—Alzheimer's disease	0.00392	0.00477	CcSEcCtD
Nadolol—Affect lability—Memantine—Alzheimer's disease	0.00389	0.00473	CcSEcCtD
Nadolol—Diplopia—Rivastigmine—Alzheimer's disease	0.00387	0.0047	CcSEcCtD
Nadolol—Hallucination—Galantamine—Alzheimer's disease	0.00386	0.0047	CcSEcCtD
Nadolol—Gastritis—Donepezil—Alzheimer's disease	0.00385	0.00469	CcSEcCtD
Nadolol—Disturbance in sexual arousal—Rivastigmine—Alzheimer's disease	0.00383	0.00467	CcSEcCtD
Nadolol—Affect lability—Rivastigmine—Alzheimer's disease	0.0038	0.00463	CcSEcCtD
Nadolol—Abdominal distension—Donepezil—Alzheimer's disease	0.00379	0.00461	CcSEcCtD
Nadolol—Irritability—Memantine—Alzheimer's disease	0.00377	0.00459	CcSEcCtD
Nadolol—Visual impairment—Galantamine—Alzheimer's disease	0.00374	0.00456	CcSEcCtD
Nadolol—Mood swings—Memantine—Alzheimer's disease	0.00374	0.00455	CcSEcCtD
Nadolol—Mood swings—Rivastigmine—Alzheimer's disease	0.00366	0.00446	CcSEcCtD
Nadolol—Tinnitus—Galantamine—Alzheimer's disease	0.00362	0.00441	CcSEcCtD
Nadolol—Dry skin—Memantine—Alzheimer's disease	0.00362	0.00441	CcSEcCtD
Nadolol—Abdominal discomfort—Donepezil—Alzheimer's disease	0.00361	0.00439	CcSEcCtD
Nadolol—Dry skin—Rivastigmine—Alzheimer's disease	0.00354	0.00431	CcSEcCtD
Nadolol—Gastritis—Memantine—Alzheimer's disease	0.0035	0.00426	CcSEcCtD
Nadolol—Weight increased—Donepezil—Alzheimer's disease	0.00342	0.00417	CcSEcCtD
Nadolol—Gastritis—Rivastigmine—Alzheimer's disease	0.00342	0.00416	CcSEcCtD
Nadolol—Bronchospasm—Memantine—Alzheimer's disease	0.00336	0.00409	CcSEcCtD
Nadolol—Depression—Donepezil—Alzheimer's disease	0.00334	0.00407	CcSEcCtD
Nadolol—Flatulence—Galantamine—Alzheimer's disease	0.00333	0.00405	CcSEcCtD
Nadolol—Bronchospasm—Rivastigmine—Alzheimer's disease	0.00329	0.004	CcSEcCtD
Nadolol—Conjunctivitis—Donepezil—Alzheimer's disease	0.00326	0.00397	CcSEcCtD
Nadolol—Sweating—Donepezil—Alzheimer's disease	0.00321	0.00391	CcSEcCtD
Nadolol—Vision blurred—Galantamine—Alzheimer's disease	0.00319	0.00388	CcSEcCtD
Nadolol—Erectile dysfunction—Memantine—Alzheimer's disease	0.00314	0.00383	CcSEcCtD
Nadolol—Weight increased—Memantine—Alzheimer's disease	0.00311	0.00378	CcSEcCtD
Nadolol—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.00308	0.00374	CcSEcCtD
Nadolol—Bradycardia—Donepezil—Alzheimer's disease	0.00306	0.00373	CcSEcCtD
Nadolol—Weight increased—Rivastigmine—Alzheimer's disease	0.00304	0.0037	CcSEcCtD
Nadolol—Depression—Memantine—Alzheimer's disease	0.00304	0.00369	CcSEcCtD
Nadolol—Syncope—Galantamine—Alzheimer's disease	0.00303	0.00369	CcSEcCtD
Nadolol—Hallucination—Donepezil—Alzheimer's disease	0.003	0.00364	CcSEcCtD
Nadolol—Loss of consciousness—Galantamine—Alzheimer's disease	0.00297	0.00362	CcSEcCtD
Nadolol—Depression—Rivastigmine—Alzheimer's disease	0.00297	0.00361	CcSEcCtD
Nadolol—Conjunctivitis—Memantine—Alzheimer's disease	0.00296	0.0036	CcSEcCtD
Nadolol—Cough—Galantamine—Alzheimer's disease	0.00295	0.00359	CcSEcCtD
Nadolol—Hypertension—Galantamine—Alzheimer's disease	0.00292	0.00355	CcSEcCtD
Nadolol—Visual impairment—Donepezil—Alzheimer's disease	0.0029	0.00353	CcSEcCtD
Nadolol—Conjunctivitis—Rivastigmine—Alzheimer's disease	0.0029	0.00352	CcSEcCtD
Nadolol—Chest pain—Galantamine—Alzheimer's disease	0.00288	0.0035	CcSEcCtD
Nadolol—Sweating—Rivastigmine—Alzheimer's disease	0.00286	0.00347	CcSEcCtD
Nadolol—Agranulocytosis—Memantine—Alzheimer's disease	0.00284	0.00346	CcSEcCtD
Nadolol—Dry mouth—Galantamine—Alzheimer's disease	0.00282	0.00343	CcSEcCtD
Nadolol—Tinnitus—Donepezil—Alzheimer's disease	0.00281	0.00342	CcSEcCtD
Nadolol—Bradycardia—Memantine—Alzheimer's disease	0.00278	0.00339	CcSEcCtD
Nadolol—Bradycardia—Rivastigmine—Alzheimer's disease	0.00272	0.00331	CcSEcCtD
Nadolol—Hallucination—Memantine—Alzheimer's disease	0.00272	0.00331	CcSEcCtD
Nadolol—Shock—Galantamine—Alzheimer's disease	0.00271	0.0033	CcSEcCtD
Nadolol—Hyperhidrosis—Galantamine—Alzheimer's disease	0.00267	0.00325	CcSEcCtD
Nadolol—Hallucination—Rivastigmine—Alzheimer's disease	0.00266	0.00324	CcSEcCtD
Nadolol—Alopecia—Donepezil—Alzheimer's disease	0.00266	0.00324	CcSEcCtD
Nadolol—Visual impairment—Memantine—Alzheimer's disease	0.00263	0.00321	CcSEcCtD
Nadolol—Anorexia—Galantamine—Alzheimer's disease	0.00263	0.0032	CcSEcCtD
Nadolol—Flatulence—Donepezil—Alzheimer's disease	0.00258	0.00314	CcSEcCtD
Nadolol—Hypotension—Galantamine—Alzheimer's disease	0.00258	0.00314	CcSEcCtD
Nadolol—Visual impairment—Rivastigmine—Alzheimer's disease	0.00258	0.00314	CcSEcCtD
Nadolol—Tinnitus—Memantine—Alzheimer's disease	0.00255	0.0031	CcSEcCtD
Nadolol—Insomnia—Galantamine—Alzheimer's disease	0.0025	0.00304	CcSEcCtD
Nadolol—Tinnitus—Rivastigmine—Alzheimer's disease	0.00249	0.00303	CcSEcCtD
Nadolol—Paraesthesia—Galantamine—Alzheimer's disease	0.00248	0.00302	CcSEcCtD
Nadolol—Vision blurred—Donepezil—Alzheimer's disease	0.00247	0.00301	CcSEcCtD
Nadolol—Dyspepsia—Galantamine—Alzheimer's disease	0.00243	0.00296	CcSEcCtD
Nadolol—Alopecia—Memantine—Alzheimer's disease	0.00242	0.00294	CcSEcCtD
Nadolol—Decreased appetite—Galantamine—Alzheimer's disease	0.0024	0.00292	CcSEcCtD
Nadolol—Fatigue—Galantamine—Alzheimer's disease	0.00238	0.0029	CcSEcCtD
Nadolol—Alopecia—Rivastigmine—Alzheimer's disease	0.00236	0.00288	CcSEcCtD
Nadolol—Constipation—Galantamine—Alzheimer's disease	0.00236	0.00287	CcSEcCtD
Nadolol—Syncope—Donepezil—Alzheimer's disease	0.00235	0.00286	CcSEcCtD
Nadolol—Flatulence—Memantine—Alzheimer's disease	0.00234	0.00285	CcSEcCtD
Nadolol—Loss of consciousness—Donepezil—Alzheimer's disease	0.0023	0.0028	CcSEcCtD
Nadolol—Flatulence—Rivastigmine—Alzheimer's disease	0.00229	0.00279	CcSEcCtD
Nadolol—Cough—Donepezil—Alzheimer's disease	0.00229	0.00278	CcSEcCtD
Nadolol—Hypertension—Donepezil—Alzheimer's disease	0.00226	0.00275	CcSEcCtD
Nadolol—Vision blurred—Memantine—Alzheimer's disease	0.00224	0.00273	CcSEcCtD
Nadolol—Chest pain—Donepezil—Alzheimer's disease	0.00223	0.00271	CcSEcCtD
Nadolol—Vision blurred—Rivastigmine—Alzheimer's disease	0.00219	0.00267	CcSEcCtD
Nadolol—Dry mouth—Donepezil—Alzheimer's disease	0.00218	0.00266	CcSEcCtD
Nadolol—Body temperature increased—Galantamine—Alzheimer's disease	0.00218	0.00265	CcSEcCtD
Nadolol—Oedema—Donepezil—Alzheimer's disease	0.00214	0.0026	CcSEcCtD
Nadolol—Syncope—Memantine—Alzheimer's disease	0.00213	0.0026	CcSEcCtD
Nadolol—Shock—Donepezil—Alzheimer's disease	0.0021	0.00256	CcSEcCtD
Nadolol—Loss of consciousness—Memantine—Alzheimer's disease	0.00209	0.00254	CcSEcCtD
Nadolol—Syncope—Rivastigmine—Alzheimer's disease	0.00209	0.00254	CcSEcCtD
Nadolol—Cough—Memantine—Alzheimer's disease	0.00208	0.00253	CcSEcCtD
Nadolol—Hyperhidrosis—Donepezil—Alzheimer's disease	0.00207	0.00252	CcSEcCtD
Nadolol—Hypertension—Memantine—Alzheimer's disease	0.00205	0.0025	CcSEcCtD
Nadolol—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.00205	0.00249	CcSEcCtD
Nadolol—Anorexia—Donepezil—Alzheimer's disease	0.00204	0.00248	CcSEcCtD
Nadolol—Cough—Rivastigmine—Alzheimer's disease	0.00203	0.00247	CcSEcCtD
Nadolol—Chest pain—Memantine—Alzheimer's disease	0.00203	0.00247	CcSEcCtD
Nadolol—Hypertension—Rivastigmine—Alzheimer's disease	0.00201	0.00245	CcSEcCtD
Nadolol—Hypotension—Donepezil—Alzheimer's disease	0.002	0.00243	CcSEcCtD
Nadolol—Chest pain—Rivastigmine—Alzheimer's disease	0.00198	0.00241	CcSEcCtD
Nadolol—Dry mouth—Memantine—Alzheimer's disease	0.00198	0.00241	CcSEcCtD
Nadolol—Asthenia—Galantamine—Alzheimer's disease	0.00198	0.00241	CcSEcCtD
Nadolol—Oedema—Memantine—Alzheimer's disease	0.00194	0.00236	CcSEcCtD
Nadolol—Dry mouth—Rivastigmine—Alzheimer's disease	0.00194	0.00236	CcSEcCtD
Nadolol—Insomnia—Donepezil—Alzheimer's disease	0.00193	0.00235	CcSEcCtD
Nadolol—Paraesthesia—Donepezil—Alzheimer's disease	0.00192	0.00234	CcSEcCtD
Nadolol—Shock—Memantine—Alzheimer's disease	0.00191	0.00232	CcSEcCtD
Nadolol—Dyspnoea—Donepezil—Alzheimer's disease	0.00191	0.00232	CcSEcCtD
Nadolol—Oedema—Rivastigmine—Alzheimer's disease	0.0019	0.00231	CcSEcCtD
Nadolol—Diarrhoea—Galantamine—Alzheimer's disease	0.00189	0.0023	CcSEcCtD
Nadolol—Dyspepsia—Donepezil—Alzheimer's disease	0.00188	0.00229	CcSEcCtD
Nadolol—Hyperhidrosis—Memantine—Alzheimer's disease	0.00188	0.00228	CcSEcCtD
Nadolol—Shock—Rivastigmine—Alzheimer's disease	0.00187	0.00227	CcSEcCtD
Nadolol—Decreased appetite—Donepezil—Alzheimer's disease	0.00186	0.00226	CcSEcCtD
Nadolol—Anorexia—Memantine—Alzheimer's disease	0.00185	0.00225	CcSEcCtD
Nadolol—Fatigue—Donepezil—Alzheimer's disease	0.00184	0.00224	CcSEcCtD
Nadolol—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.00184	0.00223	CcSEcCtD
Nadolol—Pain—Donepezil—Alzheimer's disease	0.00183	0.00223	CcSEcCtD
Nadolol—Constipation—Donepezil—Alzheimer's disease	0.00183	0.00223	CcSEcCtD
Nadolol—Dizziness—Galantamine—Alzheimer's disease	0.00182	0.00222	CcSEcCtD
Nadolol—Hypotension—Memantine—Alzheimer's disease	0.00181	0.00221	CcSEcCtD
Nadolol—Anorexia—Rivastigmine—Alzheimer's disease	0.00181	0.0022	CcSEcCtD
Nadolol—Hypotension—Rivastigmine—Alzheimer's disease	0.00178	0.00216	CcSEcCtD
Nadolol—Insomnia—Memantine—Alzheimer's disease	0.00176	0.00214	CcSEcCtD
Nadolol—Vomiting—Galantamine—Alzheimer's disease	0.00175	0.00214	CcSEcCtD
Nadolol—Paraesthesia—Memantine—Alzheimer's disease	0.00174	0.00212	CcSEcCtD
Nadolol—Rash—Galantamine—Alzheimer's disease	0.00174	0.00212	CcSEcCtD
Nadolol—Dermatitis—Galantamine—Alzheimer's disease	0.00174	0.00212	CcSEcCtD
Nadolol—Dyspnoea—Memantine—Alzheimer's disease	0.00173	0.00211	CcSEcCtD
Nadolol—Insomnia—Rivastigmine—Alzheimer's disease	0.00172	0.00209	CcSEcCtD
Nadolol—Dyspepsia—Memantine—Alzheimer's disease	0.00171	0.00208	CcSEcCtD
Nadolol—Paraesthesia—Rivastigmine—Alzheimer's disease	0.00171	0.00208	CcSEcCtD
Nadolol—Dyspnoea—Rivastigmine—Alzheimer's disease	0.00169	0.00206	CcSEcCtD
Nadolol—Body temperature increased—Donepezil—Alzheimer's disease	0.00169	0.00206	CcSEcCtD
Nadolol—Decreased appetite—Memantine—Alzheimer's disease	0.00169	0.00205	CcSEcCtD
Nadolol—Fatigue—Memantine—Alzheimer's disease	0.00167	0.00204	CcSEcCtD
Nadolol—Dyspepsia—Rivastigmine—Alzheimer's disease	0.00167	0.00203	CcSEcCtD
Nadolol—Pain—Memantine—Alzheimer's disease	0.00166	0.00202	CcSEcCtD
Nadolol—Constipation—Memantine—Alzheimer's disease	0.00166	0.00202	CcSEcCtD
Nadolol—Decreased appetite—Rivastigmine—Alzheimer's disease	0.00165	0.00201	CcSEcCtD
Nadolol—Nausea—Galantamine—Alzheimer's disease	0.00164	0.00199	CcSEcCtD
Nadolol—Fatigue—Rivastigmine—Alzheimer's disease	0.00164	0.00199	CcSEcCtD
Nadolol—Constipation—Rivastigmine—Alzheimer's disease	0.00162	0.00198	CcSEcCtD
Nadolol—Pain—Rivastigmine—Alzheimer's disease	0.00162	0.00198	CcSEcCtD
Nadolol—Carteolol—CYP2D6—Alzheimer's disease	0.0016	0.641	CrCbGaD
Nadolol—Body temperature increased—Memantine—Alzheimer's disease	0.00154	0.00187	CcSEcCtD
Nadolol—Asthenia—Donepezil—Alzheimer's disease	0.00153	0.00187	CcSEcCtD
Nadolol—Pruritus—Donepezil—Alzheimer's disease	0.00151	0.00184	CcSEcCtD
Nadolol—Body temperature increased—Rivastigmine—Alzheimer's disease	0.0015	0.00183	CcSEcCtD
Nadolol—Diarrhoea—Donepezil—Alzheimer's disease	0.00146	0.00178	CcSEcCtD
Nadolol—Dizziness—Donepezil—Alzheimer's disease	0.00141	0.00172	CcSEcCtD
Nadolol—Asthenia—Memantine—Alzheimer's disease	0.00139	0.0017	CcSEcCtD
Nadolol—Pruritus—Memantine—Alzheimer's disease	0.00137	0.00167	CcSEcCtD
Nadolol—Asthenia—Rivastigmine—Alzheimer's disease	0.00136	0.00166	CcSEcCtD
Nadolol—Vomiting—Donepezil—Alzheimer's disease	0.00136	0.00165	CcSEcCtD
Nadolol—Rash—Donepezil—Alzheimer's disease	0.00135	0.00164	CcSEcCtD
Nadolol—Dermatitis—Donepezil—Alzheimer's disease	0.00135	0.00164	CcSEcCtD
Nadolol—Pruritus—Rivastigmine—Alzheimer's disease	0.00134	0.00164	CcSEcCtD
Nadolol—Diarrhoea—Memantine—Alzheimer's disease	0.00133	0.00162	CcSEcCtD
Nadolol—Diarrhoea—Rivastigmine—Alzheimer's disease	0.0013	0.00158	CcSEcCtD
Nadolol—Dizziness—Memantine—Alzheimer's disease	0.00128	0.00156	CcSEcCtD
Nadolol—Nausea—Donepezil—Alzheimer's disease	0.00127	0.00155	CcSEcCtD
Nadolol—Dizziness—Rivastigmine—Alzheimer's disease	0.00126	0.00153	CcSEcCtD
Nadolol—Vomiting—Memantine—Alzheimer's disease	0.00123	0.0015	CcSEcCtD
Nadolol—Rash—Memantine—Alzheimer's disease	0.00122	0.00149	CcSEcCtD
Nadolol—Dermatitis—Memantine—Alzheimer's disease	0.00122	0.00149	CcSEcCtD
Nadolol—Vomiting—Rivastigmine—Alzheimer's disease	0.00121	0.00147	CcSEcCtD
Nadolol—Rash—Rivastigmine—Alzheimer's disease	0.0012	0.00146	CcSEcCtD
Nadolol—Dermatitis—Rivastigmine—Alzheimer's disease	0.0012	0.00146	CcSEcCtD
Nadolol—Nausea—Memantine—Alzheimer's disease	0.00115	0.0014	CcSEcCtD
Nadolol—Nausea—Rivastigmine—Alzheimer's disease	0.00113	0.00137	CcSEcCtD
Nadolol—Pindolol—CYP2D6—Alzheimer's disease	0.000897	0.359	CrCbGaD
Nadolol—ADRB1—GPCR ligand binding—F2—Alzheimer's disease	0.000145	0.000826	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—GAB2—Alzheimer's disease	0.000145	0.000826	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—SST—Alzheimer's disease	0.000145	0.000826	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—APP—Alzheimer's disease	0.000145	0.000823	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—HTR2A—Alzheimer's disease	0.000143	0.000815	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CDK5—Alzheimer's disease	0.000142	0.000809	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—F2—Alzheimer's disease	0.000142	0.000808	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—APP—Alzheimer's disease	0.000142	0.000805	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—NPS—Alzheimer's disease	0.000141	0.000804	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—NPS—Alzheimer's disease	0.000141	0.0008	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—PPP3CA—Alzheimer's disease	0.000141	0.0008	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—PPP3CA—Alzheimer's disease	0.00014	0.000796	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—HTR6—Alzheimer's disease	0.00014	0.000796	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—F2—Alzheimer's disease	0.000138	0.000787	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—NPS—Alzheimer's disease	0.000138	0.000786	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—PTK2B—Alzheimer's disease	0.000138	0.000785	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—PPP3CA—Alzheimer's disease	0.000138	0.000782	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—GAPDHS—Alzheimer's disease	0.000138	0.000782	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—HTR6—Alzheimer's disease	0.000137	0.000779	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—PLCB1—Alzheimer's disease	0.000137	0.000777	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—CP—Alzheimer's disease	0.000136	0.000773	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—SST—Alzheimer's disease	0.000135	0.000767	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—GAB2—Alzheimer's disease	0.000135	0.000767	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—GAB2—Alzheimer's disease	0.000134	0.000763	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—SST—Alzheimer's disease	0.000134	0.000763	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—NTRK2—Alzheimer's disease	0.000134	0.000763	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—Alzheimer's disease	0.000134	0.000763	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—CALM1—Alzheimer's disease	0.000134	0.00076	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—PLCB1—Alzheimer's disease	0.000134	0.00076	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—GSK3A—Alzheimer's disease	0.000133	0.000757	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—GAB2—Alzheimer's disease	0.000132	0.00075	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—SST—Alzheimer's disease	0.000132	0.00075	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—APP—Alzheimer's disease	0.000131	0.000747	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—APP—Alzheimer's disease	0.000131	0.000744	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—ATP5A1—Alzheimer's disease	0.00013	0.000742	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—CCL2—Alzheimer's disease	0.000129	0.000736	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—Alzheimer's disease	0.000129	0.000734	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—APP—Alzheimer's disease	0.000129	0.000731	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—PSENEN—Alzheimer's disease	0.000127	0.000723	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—CCL2—Alzheimer's disease	0.000127	0.00072	CbGpPWpGaD
Nadolol—ABCB1—HIF-1-alpha transcription factor network—AKT1—Alzheimer's disease	0.000126	0.000715	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—F2—Alzheimer's disease	0.000126	0.000714	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—APH1A—Alzheimer's disease	0.000125	0.000713	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—PLD3—Alzheimer's disease	0.000124	0.000707	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—PSENEN—Alzheimer's disease	0.000124	0.000707	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—PLCB1—Alzheimer's disease	0.000124	0.000705	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—PLCB1—Alzheimer's disease	0.000123	0.000702	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—APH1A—Alzheimer's disease	0.000123	0.000697	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—NCSTN—Alzheimer's disease	0.000122	0.000694	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—PLCB1—Alzheimer's disease	0.000121	0.00069	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—NCSTN—Alzheimer's disease	0.000119	0.000679	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—HSD17B10—Alzheimer's disease	0.000119	0.000678	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—LRP1—Alzheimer's disease	0.000119	0.000677	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—LRP1—Alzheimer's disease	0.000116	0.000662	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—GAL—Alzheimer's disease	0.000116	0.000661	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—GFAP—Alzheimer's disease	0.000116	0.000661	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—TF—Alzheimer's disease	0.000116	0.000657	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—NGFR—Alzheimer's disease	0.000115	0.000655	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—CYP46A1—Alzheimer's disease	0.000115	0.000653	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—CREB1—Alzheimer's disease	0.000114	0.000651	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—GFAP—Alzheimer's disease	0.000114	0.000647	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—GAL—Alzheimer's disease	0.000114	0.000647	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—Alzheimer's disease	0.000113	0.00064	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—ADAM10—Alzheimer's disease	0.000112	0.00064	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—CCL2—Alzheimer's disease	0.000112	0.000637	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—ND1—Alzheimer's disease	0.000111	0.000631	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Alzheimer's disease	0.000107	0.000608	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—S100B—Alzheimer's disease	0.000106	0.000605	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—A2M—Alzheimer's disease	0.000102	0.000583	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—IGF2—Alzheimer's disease	0.000101	0.000576	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—PRKCG—Alzheimer's disease	0.000101	0.000574	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—A2M—Alzheimer's disease	0.0001	0.00057	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—Alzheimer's disease	9.93e-05	0.000565	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—PSEN2—Alzheimer's disease	9.92e-05	0.000564	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—PRKCG—Alzheimer's disease	9.88e-05	0.000562	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—IGF1R—Alzheimer's disease	9.79e-05	0.000557	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—PSEN2—Alzheimer's disease	9.7e-05	0.000552	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—CCR5—Alzheimer's disease	9.57e-05	0.000544	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—LPL—Alzheimer's disease	9.38e-05	0.000534	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—HTR2A—Alzheimer's disease	9.36e-05	0.000533	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—CCR5—Alzheimer's disease	9.36e-05	0.000532	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—MEF2C—Alzheimer's disease	9.3e-05	0.000529	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—PRKCG—Alzheimer's disease	9.17e-05	0.000521	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—HTR2A—Alzheimer's disease	9.16e-05	0.000521	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—NPY—Alzheimer's disease	9.13e-05	0.000519	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—PRKCG—Alzheimer's disease	9.12e-05	0.000519	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—Alzheimer's disease	9.12e-05	0.000519	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—IAPP—Alzheimer's disease	9.07e-05	0.000516	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—PRKCG—Alzheimer's disease	8.97e-05	0.00051	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—NPY—Alzheimer's disease	8.93e-05	0.000508	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—NGF—Alzheimer's disease	8.89e-05	0.000506	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—IAPP—Alzheimer's disease	8.87e-05	0.000505	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CRH—Alzheimer's disease	8.81e-05	0.000501	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—CCR5—Alzheimer's disease	8.69e-05	0.000494	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CCR5—Alzheimer's disease	8.65e-05	0.000492	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CRH—Alzheimer's disease	8.61e-05	0.00049	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—HTR2A—Alzheimer's disease	8.5e-05	0.000484	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—CCR5—Alzheimer's disease	8.5e-05	0.000483	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—HTR2A—Alzheimer's disease	8.46e-05	0.000481	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—Alzheimer's disease	8.42e-05	0.000479	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—NPS—Alzheimer's disease	8.35e-05	0.000475	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—HTR2A—Alzheimer's disease	8.32e-05	0.000473	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—PPP3CA—Alzheimer's disease	8.31e-05	0.000473	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—F2—Alzheimer's disease	8.21e-05	0.000467	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—PTK2B—Alzheimer's disease	8.19e-05	0.000466	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—NPS—Alzheimer's disease	8.17e-05	0.000465	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—PPP3CA—Alzheimer's disease	8.13e-05	0.000462	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	8.08e-05	0.00046	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—F2—Alzheimer's disease	8.03e-05	0.000457	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—PTK2B—Alzheimer's disease	8.01e-05	0.000456	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—SST—Alzheimer's disease	7.96e-05	0.000453	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—NTRK2—Alzheimer's disease	7.96e-05	0.000453	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—GAB2—Alzheimer's disease	7.96e-05	0.000453	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—CALM1—Alzheimer's disease	7.93e-05	0.000451	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—GSK3A—Alzheimer's disease	7.89e-05	0.000449	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CALM1—Alzheimer's disease	7.89e-05	0.000449	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—APOE—Alzheimer's disease	7.87e-05	0.000447	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—LEP—Alzheimer's disease	7.87e-05	0.000447	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CAV1—Alzheimer's disease	7.79e-05	0.000443	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—GAB2—Alzheimer's disease	7.79e-05	0.000443	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—SST—Alzheimer's disease	7.79e-05	0.000443	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—NTRK2—Alzheimer's disease	7.79e-05	0.000443	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—APP—Alzheimer's disease	7.76e-05	0.000441	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—CALM1—Alzheimer's disease	7.76e-05	0.000441	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—Alzheimer's disease	7.73e-05	0.00044	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—GSK3A—Alzheimer's disease	7.72e-05	0.000439	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—APP—Alzheimer's disease	7.59e-05	0.000432	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—ESR1—Alzheimer's disease	7.51e-05	0.000427	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—F2—Alzheimer's disease	7.45e-05	0.000424	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—F2—Alzheimer's disease	7.42e-05	0.000422	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—PLCB1—Alzheimer's disease	7.32e-05	0.000417	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—F2—Alzheimer's disease	7.29e-05	0.000415	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—NOTCH1—Alzheimer's disease	7.26e-05	0.000413	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Alzheimer's disease	7.22e-05	0.000411	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—PLCB1—Alzheimer's disease	7.16e-05	0.000407	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—TPI1—Alzheimer's disease	7.14e-05	0.000406	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—CHAT—Alzheimer's disease	7.14e-05	0.000406	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—MAOB—Alzheimer's disease	6.85e-05	0.00039	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—NGFR—Alzheimer's disease	6.83e-05	0.000389	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—GSK3B—Alzheimer's disease	6.81e-05	0.000388	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—CREB1—Alzheimer's disease	6.79e-05	0.000386	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CREB1—Alzheimer's disease	6.76e-05	0.000384	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—INS—Alzheimer's disease	6.72e-05	0.000382	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—NGFR—Alzheimer's disease	6.68e-05	0.00038	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—ADAM10—Alzheimer's disease	6.67e-05	0.00038	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—CCL2—Alzheimer's disease	6.64e-05	0.000378	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—CREB1—Alzheimer's disease	6.64e-05	0.000378	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CCL2—Alzheimer's disease	6.61e-05	0.000376	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—GAPDH—Alzheimer's disease	6.59e-05	0.000375	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—ADAM10—Alzheimer's disease	6.53e-05	0.000371	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—IGF1—Alzheimer's disease	6.5e-05	0.00037	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—CCL2—Alzheimer's disease	6.5e-05	0.00037	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—A2M—Alzheimer's disease	6.37e-05	0.000362	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Alzheimer's disease	6.37e-05	0.000362	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—S100B—Alzheimer's disease	6.31e-05	0.000359	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—S100B—Alzheimer's disease	6.17e-05	0.000351	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—IGF2—Alzheimer's disease	6.01e-05	0.000342	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—NOS3—Alzheimer's disease	5.89e-05	0.000335	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—IGF2—Alzheimer's disease	5.88e-05	0.000334	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—IGF1R—Alzheimer's disease	5.81e-05	0.00033	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—IGF1R—Alzheimer's disease	5.68e-05	0.000323	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—LPL—Alzheimer's disease	5.57e-05	0.000317	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—ACHE—Alzheimer's disease	5.54e-05	0.000315	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—MEF2C—Alzheimer's disease	5.52e-05	0.000314	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—INPP5D—Alzheimer's disease	5.47e-05	0.000311	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—LPL—Alzheimer's disease	5.45e-05	0.00031	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—PRKCG—Alzheimer's disease	5.42e-05	0.000308	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—MEF2C—Alzheimer's disease	5.4e-05	0.000307	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—Alzheimer's disease	5.38e-05	0.000306	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—PRKCG—Alzheimer's disease	5.3e-05	0.000301	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—NGF—Alzheimer's disease	5.28e-05	0.0003	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—ENO1—Alzheimer's disease	5.19e-05	0.000295	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—PTGS1—Alzheimer's disease	5.19e-05	0.000295	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—NGF—Alzheimer's disease	5.16e-05	0.000294	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CCR5—Alzheimer's disease	5.13e-05	0.000292	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—CYP2D6—Alzheimer's disease	5.09e-05	0.00029	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—AKT1—Alzheimer's disease	5.05e-05	0.000287	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—HTR2A—Alzheimer's disease	5.02e-05	0.000286	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CCR5—Alzheimer's disease	5.02e-05	0.000286	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CASP3—Alzheimer's disease	5e-05	0.000285	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—IL6—Alzheimer's disease	4.97e-05	0.000283	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—HTR2A—Alzheimer's disease	4.91e-05	0.000279	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—BCHE—Alzheimer's disease	4.82e-05	0.000274	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CALM1—Alzheimer's disease	4.69e-05	0.000267	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—APOE—Alzheimer's disease	4.67e-05	0.000266	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—LEP—Alzheimer's disease	4.67e-05	0.000266	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CAV1—Alzheimer's disease	4.63e-05	0.000263	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—MAPK8—Alzheimer's disease	4.6e-05	0.000262	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—AKT1—Alzheimer's disease	4.59e-05	0.000261	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CALM1—Alzheimer's disease	4.58e-05	0.000261	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—APOE—Alzheimer's disease	4.57e-05	0.00026	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—LEP—Alzheimer's disease	4.57e-05	0.00026	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—PLCB1—Alzheimer's disease	4.55e-05	0.000259	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CAV1—Alzheimer's disease	4.52e-05	0.000257	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—ESR1—Alzheimer's disease	4.46e-05	0.000254	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—ABCA1—Alzheimer's disease	4.41e-05	0.000251	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—F2—Alzheimer's disease	4.4e-05	0.00025	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—ESR1—Alzheimer's disease	4.36e-05	0.000248	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—NOTCH1—Alzheimer's disease	4.31e-05	0.000245	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—F2—Alzheimer's disease	4.31e-05	0.000245	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—VEGFA—Alzheimer's disease	4.25e-05	0.000242	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—NOTCH1—Alzheimer's disease	4.21e-05	0.00024	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—GSK3B—Alzheimer's disease	4.04e-05	0.00023	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CREB1—Alzheimer's disease	4.01e-05	0.000228	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—INS—Alzheimer's disease	3.99e-05	0.000227	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—GSK3B—Alzheimer's disease	3.96e-05	0.000225	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CCL2—Alzheimer's disease	3.92e-05	0.000223	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CREB1—Alzheimer's disease	3.92e-05	0.000223	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—INS—Alzheimer's disease	3.9e-05	0.000222	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—TGFB1—Alzheimer's disease	3.9e-05	0.000222	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—IGF1—Alzheimer's disease	3.86e-05	0.000219	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CCL2—Alzheimer's disease	3.84e-05	0.000218	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	3.8e-05	0.000216	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—HMOX1—Alzheimer's disease	3.79e-05	0.000215	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—IGF1—Alzheimer's disease	3.77e-05	0.000215	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—NOS3—Alzheimer's disease	3.5e-05	0.000199	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—LPL—Alzheimer's disease	3.46e-05	0.000197	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—NOS3—Alzheimer's disease	3.42e-05	0.000195	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—TP53—Alzheimer's disease	3.21e-05	0.000182	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—MTHFR—Alzheimer's disease	3.12e-05	0.000177	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—AKT1—Alzheimer's disease	3e-05	0.00017	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CASP3—Alzheimer's disease	2.97e-05	0.000169	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—IL6—Alzheimer's disease	2.95e-05	0.000168	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—IL6—Alzheimer's disease	2.94e-05	0.000167	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—AKT1—Alzheimer's disease	2.93e-05	0.000167	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—CALM1—Alzheimer's disease	2.91e-05	0.000166	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CASP3—Alzheimer's disease	2.9e-05	0.000165	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—APOE—Alzheimer's disease	2.9e-05	0.000165	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—IL6—Alzheimer's disease	2.89e-05	0.000164	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—CAV1—Alzheimer's disease	2.88e-05	0.000164	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—MAPK8—Alzheimer's disease	2.73e-05	0.000155	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—AKT1—Alzheimer's disease	2.72e-05	0.000155	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—AKT1—Alzheimer's disease	2.71e-05	0.000154	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—MAPK8—Alzheimer's disease	2.67e-05	0.000152	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—AKT1—Alzheimer's disease	2.66e-05	0.000151	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—PPARG—Alzheimer's disease	2.53e-05	0.000144	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—VEGFA—Alzheimer's disease	2.52e-05	0.000143	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—INS—Alzheimer's disease	2.48e-05	0.000141	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—VEGFA—Alzheimer's disease	2.46e-05	0.00014	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—TGFB1—Alzheimer's disease	2.31e-05	0.000132	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—TGFB1—Alzheimer's disease	2.26e-05	0.000129	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—NOS3—Alzheimer's disease	2.17e-05	0.000124	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—PTGS2—Alzheimer's disease	1.99e-05	0.000113	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—TP53—Alzheimer's disease	1.9e-05	0.000108	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—TP53—Alzheimer's disease	1.86e-05	0.000106	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—IL6—Alzheimer's disease	1.74e-05	9.91e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—IL6—Alzheimer's disease	1.7e-05	9.7e-05	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—AKT1—Alzheimer's disease	1.61e-05	9.15e-05	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—AKT1—Alzheimer's disease	1.57e-05	8.95e-05	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—AKT1—Alzheimer's disease	1e-05	5.69e-05	CbGpPWpGaD
